Stay updated with breaking news from Paul Rickey. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report) insider James Paul Rickey sold 11,600 shares of the company’s stock in a transaction dated Thursday, December 14th. The stock was sold at an average price of $19.00, for a total transaction of $220,400.00. The sale was disclosed in a filing with the Securities & Exchange […]
Alpine Immune Sciences Appoints Natasha Hernday to Board of Directors SEATTLE--(Business Wire)--Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune/inflammatory diseases, today announced that Natasha A. Hernday has joined Alpine’s Board of Directors. Ms. Hernday brings more than 20 years of experience in corporate development and corporate strategy. “I’m delighted to welcome Natasha to Alpine Immune Sciences’ Board at this important moment in our company’s history, as we b...